Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Micro Array-Assisted Analysis of Anti-Schistosome Glycan Antibodies Elicited by Protective Vaccination With Irradiated Cercariae.

Yang YYM, Wilson RA, Thomas SRL, Kariuki TM, van Diepen A, Hokke CH.

J Infect Dis. 2019 Apr 19;219(10):1671-1680. doi: 10.1093/infdis/jiy714.

PMID:
30561696
2.

Dominance rank-associated gene expression is widespread, sex-specific, and a precursor to high social status in wild male baboons.

Lea AJ, Akinyi MY, Nyakundi R, Mareri P, Nyundo F, Kariuki T, Alberts SC, Archie EA, Tung J.

Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12163-E12171. doi: 10.1073/pnas.1811967115. Epub 2018 Dec 11.

3.

Diagnosis of schistosomiasis mansoni: an evaluation of existing methods and research towards single worm pair detection.

Ogongo P, Kariuki TM, Wilson RA.

Parasitology. 2018 Sep;145(11):1355-1366. doi: 10.1017/S0031182018000240. Epub 2018 Mar 6. Review.

PMID:
29506583
4.

Diurnal transcriptome atlas of a primate across major neural and peripheral tissues.

Mure LS, Le HD, Benegiamo G, Chang MW, Rios L, Jillani N, Ngotho M, Kariuki T, Dkhissi-Benyahya O, Cooper HM, Panda S.

Science. 2018 Mar 16;359(6381). pii: eaao0318. doi: 10.1126/science.aao0318. Epub 2018 Feb 8.

5.

Health research: Africa-India health-science partnerships.

Jameel S, Kariuki T, Kay S.

Nature. 2016 Sep 22;537(7621):488. doi: 10.1038/537488d. No abstract available.

PMID:
27652554
6.

Protective Effect of Chronic Schistosomiasis in Baboons Coinfected with Schistosoma mansoni and Plasmodium knowlesi.

Nyakundi RK, Nyamongo O, Maamun J, Akinyi M, Mulei I, Farah IO, Blankenship D, Grimberg B, Hau J, Malhotra I, Ozwara H, King CL, Kariuki TM.

Infect Immun. 2016 Apr 22;84(5):1320-1330. doi: 10.1128/IAI.00490-15. Print 2016 May.

7.

Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model.

Carvalho-Queiroz C, Nyakundi R, Ogongo P, Rikoi H, Egilmez NK, Farah IO, Kariuki TM, LoVerde PT.

Front Immunol. 2015 Jun 2;6:273. doi: 10.3389/fimmu.2015.00273. eCollection 2015.

8.

Enabling the Development and Deployment of Next Generation Point-of-Care Diagnostics.

Derda R, Gitaka J, Klapperich CM, Mace CR, Kumar AA, Lieberman M, Linnes JC, Jores J, Nasimolo J, Ndung'u J, Taracha E, Weaver A, Weibel DB, Kariuki TM, Yager P.

PLoS Negl Trop Dis. 2015 May 14;9(5):e0003676. doi: 10.1371/journal.pntd.0003676. eCollection 2015 May. No abstract available. Erratum in: PLoS Negl Trop Dis. 2015 Jun;9(6):e0003857.

9.

Improved sensitivity of the urine CAA lateral-flow assay for diagnosing active Schistosoma infections by using larger sample volumes.

Corstjens PL, Nyakundi RK, de Dood CJ, Kariuki TM, Ochola EA, Karanja DM, Mwinzi PN, van Dam GJ.

Parasit Vectors. 2015 Apr 22;8:241. doi: 10.1186/s13071-015-0857-7.

10.

The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2.

Gil L, Marcos E, Izquierdo A, Lazo L, Valdés I, Ambala P, Ochola L, Hitler R, Suzarte E, Álvarez M, Kimiti P, Ndung'u J, Kariuki T, Guzmán MG, Guillén G, Hermida L.

Immunol Cell Biol. 2015 Jan;93(1):57-66. doi: 10.1038/icb.2014.63. Epub 2014 Sep 2.

PMID:
25178969
11.

Tools for diagnosis, monitoring and screening of Schistosoma infections utilizing lateral-flow based assays and upconverting phosphor labels.

Corstjens PL, De Dood CJ, Kornelis D, Fat EM, Wilson RA, Kariuki TM, Nyakundi RK, Loverde PT, Abrams WR, Tanke HJ, Van Lieshout L, Deelder AM, Van Dam GJ.

Parasitology. 2014 Dec;141(14):1841-55. doi: 10.1017/S0031182014000626. Epub 2014 Jun 16. Review.

12.

Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys.

Gil L, Izquierdo A, Lazo L, Valdés I, Ambala P, Ochola L, Marcos E, Suzarte E, Kariuki T, Guzmán G, Guillén G, Hermida L.

Virology. 2014 May;456-457:70-6. doi: 10.1016/j.virol.2014.03.011. Epub 2014 Mar 29.

13.

Olive baboons: a non-human primate model for testing dengue virus type 2 replication.

Valdés I, Gil L, Castro J, Odoyo D, Hitler R, Munene E, Romero Y, Ochola L, Cosme K, Kariuki T, Guillén G, Hermida L.

Int J Infect Dis. 2013 Dec;17(12):e1176-81. doi: 10.1016/j.ijid.2013.08.007. Epub 2013 Sep 16.

14.

Functional evaluation of malaria Pfs25 DNA vaccine by in vivo electroporation in olive baboons.

Kumar R, Nyakundi R, Kariuki T, Ozwara H, Nyamongo O, Mlambo G, Ellefsen B, Hannaman D, Kumar N.

Vaccine. 2013 Jun 28;31(31):3140-7. doi: 10.1016/j.vaccine.2013.05.006. Epub 2013 May 16.

15.

Evaluation of the European foundation initiative into African research in neglected tropical diseases by the African fellows.

O'Neill HG, Mzilahowa T, de Deus N, Njenga SM, Mmbaga EJ, Kariuki TM.

PLoS Negl Trop Dis. 2013;7(3):e2019. doi: 10.1371/journal.pntd.0002019. Epub 2013 Mar 14. No abstract available.

16.

Preclinical drug evaluation system in the Plasmodium knowlesi baboon model of malaria: the methotrexate study.

Ichagichu M, Ngotho M, Karanja SM, Kokwaro G, Kariuki T, Nzila A, Ozwara H.

J Med Primatol. 2013 Apr;42(2):62-70. doi: 10.1111/jmp.12034. Epub 2013 Jan 7.

PMID:
23294369
17.

The role of scientists and clinicians in raising public support for animal research in reproductive biology and medicine.

Dancet EA, Brännström M, Brasky K, Chai D, Chan AW, Conn PM, Else J, Falconer H, Fazleabas AT, Farah IO, Goddeeris BM, Golos TG, Hau J, Hearn JP, Kariuki TM, Kyama CM, Lebovic DI, Mwenda JM, Ndung'u J, Nyachieo A, Parker J, Slayden OD, Stouffer RL, Strauss JF, Taylor HS, Vanderpoel S, Westergaard JG, Zelinski M, D'Hooghe TM.

Biol Reprod. 2013 Feb 7;88(2):33. doi: 10.1095/biolreprod.112.105908. Print 2013 Feb. No abstract available.

PMID:
23255340
18.

Research and capacity building for control of neglected tropical diseases: the need for a different approach.

Kariuki T, Phillips R, Njenga S, Olesen OF, Klatser PR, Porro R, Lock S, Cabral MH, Gliber M, Hanne D.

PLoS Negl Trop Dis. 2011;5(5):e1020. doi: 10.1371/journal.pntd.0001020. Epub 2011 May 31. No abstract available.

19.

Prevalence of Babesia microti in free-ranging baboons and African green monkeys.

Maamun JM, Suleman MA, Akinyi M, Ozwara H, Kariuki T, Carlsson HE.

J Parasitol. 2011 Feb;97(1):63-7. doi: 10.1645/GE-2391.1. Epub 2010 Sep 28.

PMID:
21348608
20.

A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.

Chowdhury DR, Angov E, Kariuki T, Kumar N.

PLoS One. 2009 Jul 22;4(7):e6352. doi: 10.1371/journal.pone.0006352.

21.

Antibodies elicited by the secretions from schistosome cercariae and eggs are predominantly against glycan epitopes.

Kariuki TM, Farah IO, Wilson RA, Coulson PS.

Parasite Immunol. 2008 Oct;30(10):554-62. doi: 10.1111/j.1365-3024.2008.01054.x.

22.

Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities.

Boraschi D, Abebe Alemayehu M, Aseffa A, Chiodi F, Chisi J, Del Prete G, Doherty TM, Elhassan I, Engers H, Gyan B, Harandi AM, Kariuki T, Kironde F, Kouriba B, Langhorne J, Laskay T, Medaglini D, Olesen O, Onyebujoh P, Palma C, Sauerwein R, Sibanda E, Steinhoff U, Tagliabue A, Thiel A, Vahedi M, Troye-Blomberg M.

PLoS Negl Trop Dis. 2008 Jun 25;2(6):e255. doi: 10.1371/journal.pntd.0000255.

23.

Schistosome vaccine testing: lessons from the baboon model.

Coulson PS, Kariuki TM.

Mem Inst Oswaldo Cruz. 2006 Sep;101 Suppl 1:369-72.

24.

The detection limits for estimates of infection intensity in schistosomiasis mansoni established by a study in non-human primates.

Alan Wilson R, van Dam GJ, Kariuki TM, Farah IO, Deelder AM, Coulson PS.

Int J Parasitol. 2006 Oct;36(12):1241-4. Epub 2006 Aug 8.

PMID:
16930605
25.

Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine.

Kariuki TM, Van Dam GJ, Deelder AM, Farah IO, Yole DS, Wilson RA, Coulson PS.

Infect Immun. 2006 Jul;74(7):3979-86.

26.
27.

Parameters of the attenuated schistosome vaccine evaluated in the olive baboon.

Kariuki TM, Farah IO, Yole DS, Mwenda JM, Van Dam GJ, Deelder AM, Wilson RA, Coulson PS.

Infect Immun. 2004 Sep;72(9):5526-9.

28.

Morbidity and immune response to natural schistosomiasis in baboons ( Papio anubis).

Farah I, Börjesson A, Kariuki T, Yole D, Suleman M, Hau J, Carlsson HE.

Parasitol Res. 2003 Oct;91(4):344-8. Epub 2003 Sep 18.

PMID:
14574568
29.

An overview of animal models in experimental schistosomiasis and refinements in the use of non-human primates.

Farah IO, Kariuki TM, King CL, Hau J.

Lab Anim. 2001 Jul;35(3):205-12. Review.

PMID:
11463066
30.

Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4.

Farah IO, Mola PW, Kariuki TM, Nyindo M, Blanton RE, King CL.

J Immunol. 2000 May 15;164(10):5337-43.

31.

Cytokine control of the granulomatous response in Schistosoma mansoni-infected baboons: role of exposure and treatment.

Mola PW, Farah IO, Kariuki TM, Nyindo M, Blanton RE, King CL.

Infect Immun. 1999 Dec;67(12):6565-71.

32.

Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons.

Nyindo M, Kariuki TM, Mola PW, Farah IO, Elson L, Blanton RE, King CL.

Infect Immun. 1999 Feb;67(2):636-42.

33.

Schistosoma mansoni: development and modulation of the granuloma after or multiple exposures in the baboon (Papio cynocephalus anubis).

Farah IO, Nyindo M, Suleman MA, Nyaundi J, Kariuki TM, Blanton RE, Elson LH, King CL.

Exp Parasitol. 1997 Jun;86(2):93-101.

PMID:
9207739
34.

Vaccination of vervet monkeys against cutaneous leishmaniosis using recombinant Leishmania 'major surface glycoprotein' (gp63).

Olobo JO, Anjili CO, Gicheru MM, Mbati PA, Kariuki TM, Githure JI, Koech DK, McMaster WR.

Vet Parasitol. 1995 Dec;60(3-4):199-212.

PMID:
8747903
35.

Visceral leishmaniasis in vervet monkeys: immunological responses during asymptomatic infections.

Gicheru MM, Olobo JO, Kariuki TM, Adhiambo C.

Scand J Immunol. 1995 Feb;41(2):202-8.

PMID:
7863267

Supplemental Content

Loading ...
Support Center